Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Rituximab
Other

Rituximab

Tracked across 1 events · 6 articles · First seen Jun 30, 2026 · Last active Jun 30, 2026

Sentiment
60
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
6 60
Tech
BeOne BRUKINSA Phase 3 Success
Impact: Rituximab is a key component of the chemotherapy-free regimen in the MANGROVE study, used in combination with Zanubrutinib to treat mantle cell lymphoma.
Jun 30, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Rituximab live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.